G. Schlimok

ErbB2 overexpression on occult metastatic cells in bone marrow predicts poor clinical outcome of stage I-III breast cancer patients.

Sepp Braun, G. Schlimok, Isabella Heumos et al. · PubMed · 2001 · 189 citations

Medicine, Cell Biology, Oncology +14

Detection of karyotypic aberrations in acute myeloblastic leukaemia: a prospective comparison between PCR/FISH and standard cytogenetics in 140 patients with <i>de novo</i> AML

Jürgen Krauter, Wolfgang Peter, Ulrich Pascheberg et al. · British Journal of Haematology · 1998 · 63 citations

Life Sciences, Genetics, Hematology +17

Tumor cell contamination of peripheral blood stem cell transplants and bone marrow in high-risk breast cancer patients

Ralf Schulze, Monika Schulze, A. Wischnik et al. · Bone Marrow Transplantation · 1997 · 57 citations

Medicine, Hematology, Oncology +17

Long-term outcome of patients with newly diagnosed chronic myeloid leukemia: a randomized comparison of stem cell transplantation with drug treatment

Aloïs Gratwohl, Markus Pfirrmann, A. Zander et al. · Leukemia · 2015 · 55 citations · Full text

Medicine, Hematology, Cell Therapy +13

Influence of molecular subgroups on outcome of acute myeloid leukemia with normal karyotype in 141 patients undergoing salvage allogeneic stem cell transplantation in primary induction failure or beyond first relapse

Tim Pfeiffer, Michael Schleuning, Jiří Mayer et al. · Haematologica · 2012 · 32 citations · Full text

Medicine, Genetics, Oncology +15